DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Myc
Myc
Amplitude Modulation of Androgen Signaling by C-MYC
KLF6 Depletion Promotes NF-Κb Signaling in Glioblastoma
KLF6-SV1 Overexpression Accelerates Human and Mouse Prostate Cancer Progression and Metastasis
Expression Is a New Potential Biomarker for Adverse
AP-1 in Cell Proliferation and Survival
Physical Interaction of the Retinoblastoma Protein with Human D Cyclins
Genetic and Genomic Analysis Modeling of Germline C-MYC Overexpression and Cancer Susceptibility
(AR) and C-Myc for the Treatment of Prostate Cancer
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
The Leucine Zipper of C-Myc Is Required for Full Inhibition of Erythroleukemia Differentiation MICHAEL J
Sequence-Specific DNA Binding by Myc Proteins
Changes in C-Myc and C-Fos Expression in a Human Tumor Cell Line Following Exposure to Bifunctional Alkylating Agents1
STAT3 Is a Master Regulator of Epithelial Identity and KRAS-Driven Tumorigenesis
Involvement of C-Fos in the Promotion of Cancer Stem-Like Cell Properties
Increased Androgen Receptor Activity and Altered C-Myc Expression in Prostate Cancer Cells After Long-Term Androgen Deprivation1
KLF6 Transcription Factor Protects Hepatocellular Carcinoma-Derived Cells from Apoptosis
Roles of KLF6 and KLF6-Sv1in Ovarian Cancer Progression And
Therapeutic Targeting of P300/CBP HAT Domain for the Treatment of NUT Midline Carcinoma
Top View
A Synthetic Leucine Zipper-Based Dimerization System for Combining Multiple Promoter Specificities
Different Requirements for Formation of Jun: Jun and Jun : Fos Complexes
Human KLF6 ORF Mammalian Expression Plasmid, N-Myc Tag
Myc Family Oncoproteins Function Through a Common Pathway to Trans[Orm Normal Cells in Culture: Cross-Interference by Max and Trans-Acting Dominant Mutants
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas
Unravelling the Role of Lncrna WT1-AS/Mir-206/NAMPT Axis As Prognostic Biomarkers in Lung Adenocarcinoma
C Stands for C Ellular [As Opposed to V Iral Genes]
Protein Aggregation of the P63 Transcription Factor Underlies Severe
C-Fos Expression Is a Molecular Predictor of Progression and Survival in Epithelial Ovarian Carcinoma
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Discrimination Between Different E-Box-Binding Proteins at an Endogenous Target Gene Otc-Myc
How to Plan an Immunoprecipitation of Your Myc-Tagged Protein Using the Chromotek Myc-Trap
A New Immune Competent, Androgen Receptor Positive Mouse Model of Prostate Cancer Bone Metastasis
MYC in Brain Development and Cancer
A Critical Evaluation of Transactivation and Target Gene Regulation
Max: Functional Domains and Interaction with C-Myc
The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology
The MYC Transcription Factor Network: Balancing Metabolism, Proliferation and Oncogenesis
REVIEW a Tumor Suppressor and Oncogene: the WT1 Story
AP-1 Regulates Cyclin D1 and C-MYC Transcription in an AKT-Dependent Manner in Response to Mtor Inhibition: Role of AIP4/Itch-Mediated JUNB Degradation
Regulation of the Proto-Oncogenes Bcl-2 and C-Myc by the Wilms' Tumor Suppressor Gene WTJ1
The N-Myc Oncogene: Maximizing Its Targets, Regulation, and Therapeutic Potential
Small Molecules Targeting C-Myc Oncogene: Promising Anti-Cancer Therapeutics
Translocations Involving C-Myc and C-Myc Function
A Mouse Model of MYCN-Driven Retinoblastoma Reveals MYCN-Independent Tumor Reemergence
Structural and Biophysical Insights Into the Function of the Intrinsically Disordered Myc Oncoprotein
Co-Activation of Super-Enhancer-Driven CCAT1 by TP63 and SOX2 Promotes Squamous Cancer Progression
MXD/MIZ1 Complexes Activate Transcription of MYC-Repressed Genes
DYRK2 Priming Phosphorylation of C-Jun and C-Myc Modulates Cell Cycle Progression in Human Cancer Cells
The V-Jun Point Mutation Allows C-Jun to Escape GSK3-Dependent Recognition and Destruction by the Fbw7 Ubiquitin Ligase
Wilms' Tumor 1 and Signal Transducers and Activators of Transcription 3 Synergistically Promote Cell Proliferation: a Possible Mechanism in Sporadic Wilms' Tumor
P53 Mediates Apoptosis Induced by C-Myc Activation in Hypoxic Or Gamma Irradiated ®Broblasts
Suppression of Myc Oncogenic Activity by Nucleostemin Haploinsufficiency
Transcriptional Activation of C-Myc Proto-Oncogene by WT1 Protein
Reconstructing MYC
Myc-Mediated Apoptosis Requires Wild-Type P53 in a Manner Independent of Cell Cycle Arrest and the Ability of P53 to Induce P 21 W
Changes in the Expression of C-Myc, RB and Tyrosine- Phosphorylated Proteins During Proliferation of NIH 3T3 Cells Induced by Hyaluronic Acid
Crosstalk Between Myc and Activating Transcription Factor 2 (ATF2): Myc Prolongs the Half-Life and Induces Phosphorylation of ATF2